Bibliographic Details
| Title: |
Adjuvant Chemoradiation Confers a Survival Benefit in Sellar/Suprasellar Adult Atypical Teratoid Rhabdoid Tumor. |
| Authors: |
Hernandez-Rovira, Miguel A., Connor, Michelle, Osario, Rob, Russler-Germain, Emilie, Schmidt, Robert E., Johnson, Gabrielle W., Silverstein, Julie, Dahiya, Sonika, Farrell, Nyssa F., Weiss, Mia C., Zipfel, Gregory J., Huang, Jiayi, Mathios, Dimitrios |
| Source: |
Journal of Neurological Surgery. Part B. Skull Base; 2025 Supplement 1, Vol. 86, pS1-S576, 576p |
| Subject Terms: |
TERATOMA, OVERALL survival, TUMOR grading, CHEMORADIOTHERAPY, PROGNOSIS |
| Abstract: |
The article in the Journal of Neurological Surgery. Part B. Skull Base discusses the survival benefits of adjuvant chemoradiation in adult patients with sellar/suprasellar atypical teratoid rhabdoid tumors (ATRTs). A study of 48 patients revealed a significant negative correlation between age at diagnosis and overall survival, with those undergoing adjuvant chemoradiation showing a mean overall survival of 23.8 months compared to 2.65 months for those who did not. The research suggests that age at diagnosis and treatment with adjuvant chemoradiation play crucial roles in improving overall survival rates for adult patients with ATRTs. [Extracted from the article] |
|
Copyright of Journal of Neurological Surgery. Part B. Skull Base is the property of Thieme Medical Publishing Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
